ARCHIVES

Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial

This article is from The Cancer Letter archive.

Vol. 15 No. 43 | November 10, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: Patent For Semisynthetic Taxol Issued To FL Scientist; Simone To Chair Pediatric Group

June 7, 1991

Velcade Addition Can Improve Graft-Versus-Host Outcomes

December 27, 2013

NHGRI Director Francis Collins To Step Down.

May 30, 2008

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

Abstracts Of ‘Most Newsworthy’ Papers

June 10, 1977

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013